A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to ...

Colorectal cancer breaks the usual immune rules, with certain regulatory T cells linked to improved survival. In many solid ...

While human and mice tumors share many of the same molecular markers, including many shared genes, there are differences, including our natural immune responses and our immune systems in general.

On the heels of comedian Dave Coulier’s announcement of his tongue cancer diagnosis, experts are sharing what to know about the disease. Coulier, 66, announced in a Tuesday interview that he has been ...

Dave Coulier recently revealed another cancer diagnosis, mere months after recovering from Stage 3 non-Hodgkin’s lymphoma back in April. The 66-year old “Full House” actor shared that he’s been ...

Scientists at UCLA have developed an "off-the-shelf" cell-based immunotherapy that was able to track down and kill pancreatic cancer cells even after they had spread to other organs. In a mouse study, ...

Sharp Memorial Hospital is the first hospital system in San Diego to use a revolutionary technology to destroy cancerous tumors. The groundbreaking treatment, called histotripsy, focuses external ...

Throat cancer represents one of the most treatable forms of cancer when caught early, yet thousands of cases go undiagnosed until advanced stages because symptoms often masquerade as common, harmless ...